In a recent enlightening interview, Demis Hassabis of DeepMind discussed the revolutionary potential of AI in healthcare, particularly its application in drug discovery and clinical trials. Highlights included Gemini’s success in health scans and the promise of AI in rapidly developing drug therapies to treat diseases. He pointed out the exponential growth expected in this field, although emphasized the regulatory hurdles that still exist. The conversation also touched on AI as a collaborative partner in research, co-science developments, and even partnerships within gaming contexts to explore AI capabilities dynamically. The future of AI, according to Hassabis, is not only to assist in scientific discovery but to fundamentally change how we address global health challenges.